tiprankstipranks
American Shared Hospital Services (AMS)
XASE:AMS
US Market
Want to see AMS full AI Analyst Report?

American Shared Hospital Services (AMS) Earnings Dates, Call Summary & Reports

135 Followers

Earnings Data

Report Date
Aug 19, 2026
Before Open (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
-0.02
Last Year’s EPS
-0.04
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 14, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented meaningful operational and financial improvements: double-digit top-line growth (+15.9%), strong expansion in the direct patient services segment (+30.2%), adjusted EBITDA growth (+18.4%), improved gross margins (+44% in dollars) and a stronger cash position. These positives are tempered by an ongoing GAAP net loss ($0.6M), higher operating and maintenance costs associated with ramping centers, and continuing lender discussions and multi-year timelines for major projects. On balance, the company demonstrated clear operational momentum and improving financial metrics, while still managing near-term cost and financing execution risks.
Company Guidance
Management offered directional guidance rather than specific forward numbers, saying volumes are trending positively into Q2 and that continued revenue and margin expansion is expected as utilization scales; they reiterated plans for Guadalajara to begin operations late this year, a Bristol radiation therapy center in ~18–24 months and a Johnston proton center in ~24–30 months, and noted ongoing lender discussions. They pointed to Q1 results as the basis for that outlook: total revenue +15.9% to $7.1M (Direct Patient Care $4.1M, +30.2%; Leasing ≈ $3.0M), adjusted EBITDA +18.4% to $1.1M, gross margin +44% to $1.3M (18.2% vs 15.4%), proton fractions +20%+ YoY, total cost of revenue $5.8M (from $5.2M), SG&A $1.9M, operating loss improved to $(0.9)M (from $(1.3)M), net loss $(0.6)M or $0.09/diluted (vs $0.10), cash and equivalents $5.2M (from $3.7M) and current portion of long‑term debt $0.8M (from $17.3M).
Revenue Growth
Total revenue increased 15.9% year over year to $7.1M (from $6.1M), driven by stronger utilization across the network.
Direct Patient Services Expansion
Direct Patient Care Services revenue rose 30.2% YoY to ~$4.1M (from $3.1M), reflecting higher procedure volumes at Rhode Island facilities and the Puebla center.
Adjusted EBITDA Improvement
Adjusted EBITDA increased 18.4% YoY to $1.1M (from $949K), indicating improved operating performance and margin progress.
Gross Margin and Profitability Trends
Gross profit rose ~44% to $1.3M and gross margin expanded to 18.2% (from $900K and 15.4% prior year), contributing to an improved operating loss of $0.9M versus $1.3M a year ago.
Cash Position and Near-Term Liquidity
Cash, cash equivalents and restricted cash increased to ~$5.2M from $3.7M at year-end, helping address prior covenant concerns and improve financial flexibility.
Debt and Capital Structure Progress
Current portion of long-term debt fell materially to $0.8M as of 03/31/2026 from $17.3M at 12/31/2025, reducing near-term leverage pressure.
Modal Growth — Proton and Gamma Knife
Proton beam therapy volumes drove revenue growth with total fractions rising over 20% YoY; Gamma Knife revenue also increased, notably in international locations (Peru, Ecuador) after equipment upgrades and improved conditions.
Operational Ramps and Pipeline
Meaningful volume growth at Orlando PBRT, Rhode Island centers, and international Gamma Knife centers; Puebla center showing strong growth and improved reimbursement. Guadalajara center expected to begin operations late 2026; certificate of need approvals gained for new Rhode Island projects (Bristol and Johnston) providing a multi-year growth runway.
Leadership Continuity
Experienced internal appointment: Craig K. Tagawa (35+ years with company) named Interim CEO, providing continuity in operations and strategy during transition.

American Shared Hospital Services (AMS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

AMS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 19, 2026
2026 (Q2)
-0.02 / -
-0.04
May 14, 2026
2026 (Q1)
- / -
-0.1
Mar 31, 2026
2025 (Q4)
-0.01 / -0.09
-0.110.00% (+0.01)
Nov 13, 2025
2025 (Q3)
- / 0.00
-0.03
Aug 13, 2025
2025 (Q2)
- / -0.04
0.55-107.27% (-0.59)
May 15, 2025
2025 (Q1)
- / -0.10
0.02-600.00% (-0.12)
Apr 04, 2025
2024 (Q4)
0.01 / -0.10
0.02-600.00% (-0.12)
Nov 13, 2024
2024 (Q3)
0.08 / -0.03
0.018-266.67% (-0.05)
Aug 14, 2024
2024 (Q2)
0.07 / 0.55
-0.0183155.56% (+0.57)
May 14, 2024
2024 (Q1)
0.03 / 0.02
0.029-31.03% (>-0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

AMS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 14, 2026
$1.68$1.58-5.95%
Mar 31, 2026
$1.81$1.45-19.89%
Nov 13, 2025
$2.08$2.24+7.69%
Aug 13, 2025
$2.57$2.58+0.51%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does American Shared Hospital Services (AMS) report earnings?
American Shared Hospital Services (AMS) is schdueled to report earning on Aug 19, 2026, Before Open (Confirmed).
    What is American Shared Hospital Services (AMS) earnings time?
    American Shared Hospital Services (AMS) earnings time is at Aug 19, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is AMS EPS forecast?
          AMS EPS forecast for the fiscal quarter 2026 (Q2) is -0.02.